Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 2.5%. By the end of trading, Amgen fell $4.62 (-4.1%) to $109.13 on heavy volume. Throughout the day, 5,156,258 shares of Amgen exchanged hands as compared to its average daily volume of 3,261,900 shares. The stock ranged in price between $108.58-$112.64 after having opened the day at $111.70 as compared to the previous trading day's close of $113.75. Other companies within the Health Care sector that declined today were:
), down 40.8%,
), down 19.8%,
), down 14.2% and
), down 11.5%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
Amgen Inc., a biotechnology medicines company, engages in the discovery, development, manufacture, and marketing of human therapeutic products in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada. Amgen has a market cap of $79.6 billion and is part of the drugs industry. Shares are up 22.5% year to date as of the close of trading on Monday. Currently there are 7 analysts that rate Amgen a buy, no analysts rate it a sell, and 13 rate it a hold.
TheStreet Ratings rates
. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, reasonable valuation levels, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Amgen Ratings Report.
On the positive front,
), up 41.5%,
), up 22.1%,
), up 17.5% and
), up 9.7%.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
) while those bearish on the health care sector could consider
- Find other investment ideas from our top rated ETFs lists.